Article Details

orion announces the rapid lead optimization of ob-004 - a ccr2 antagonist - Financial Post

Retrieved on: 2021-11-30 18:10:15

Tags for this article:

Click the tags to see associated articles and topics

orion announces the rapid lead optimization of ob-004 - a ccr2 antagonist - Financial Post. View article details on hiswai:

Excerpt

Ottawa, Ontario, Canada, Nov. 30, 2021 (GLOBE NEWSWIRE) — Orion Biotechnology, a clinical stage company unlocking the therapeutic potential of G…

Article found on: financialpost.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up